ESCITALOPRAM tablet, film coated

국가: 미국

언어: 영어

출처: NLM (National Library of Medicine)

유효 성분:

ESCITALOPRAM OXALATE (UNII: 5U85DBW7LO) (ESCITALOPRAM - UNII:4O4S742ANY)

제공처:

Preferred Pharmaceuticals, Inc.

INN (International Name):

ESCITALOPRAM OXALATE

구성:

ESCITALOPRAM 20 mg

관리 경로:

ORAL

처방전 유형:

PRESCRIPTION DRUG

치료 징후:

Escitalopram tablet, is indicated for the acute and maintenance treatment of major depressive disorder in adults and in adolescents 12 to 17 years of age [ see Clinical Studies ( 14.1) ]. A major depressive episode (DSM-IV) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least five of the following nine symptoms: depressed mood, loss of interest in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide attempt or suicidal ideation. Escitalopram tablet, is indicated for the acute treatment of Generalized Anxiety Disorder (GAD)

제품 요약:

White to off-white, round, biconvex, film -coated tablets, debossed with "10” on one side and break line on other side. 20 mg Tablets: Bottle of 28                    NDC 68788-6783-8 Bottle of 30                    NDC 68788-6783-3 Bottle of 60                    NDC 68788-6783-6 Bottle of 90                    NDC 68788-6783-9 White to off-white, round, biconvex, film coated tablets, debossed with “20” on one side and break line on other side. Storage and Handling Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). [see USP Controlled Room Temperature].

승인 상태:

Abbreviated New Drug Application

환자 정보 전단

ESCITALOPRAM- ESCITALOPRAM TABLET, FILM COATED
Preferred Pharmaceuticals, Inc.
----------
17.2 FDA-APPROVED MEDICATION GUIDE
Medication Guide
Escitalopram Tablets
(ES-sye-TAL-oh-pram)
Read the Medication Guide that comes with escitalopram tablets before
you start taking it and each
time you get a refill. There may be new information. This Medication
Guide does not take the place
of talking to your healthcare provider about your medical condition or
treatment. Talk with your
healthcare provider if there is something you do not understand or
want to learn more about.
What is the most important information I should know about
escitalopram tablets?
Escitalopram tablets and other antidepressant medicines may cause
serious side effects, including:
1.
Suicidal thoughts or actions:
1.
Escitalopram tablets and other antidepressant medicines may increase
suicidal thoughts or
actions in some children, teenagers or young adults within the first
few months of treatment or
when the dose is changed.
2.
Depression or other serious mental illnesses are the most important
causes of suicidal
thoughts or actions.
3.
Watch for these changes and call your healthcare provider right away
if you notice:
•
New or sudden changes in mood, behavior, actions, thoughts, or
feelings, especially if
severe.
•
Pay particular attention to such changes when escitalopram tablet is
started or when the
dose is changed.
Keep all follow-up visits with your healthcare provider and call
between visits if you are worried
about symptoms.
Call your healthcare provider right away if you have any of the
following symptoms, or call 911 if
an emergency, especially if they are new, worse, or worry you:
4.
attempts to commit suicide
5.
acting on dangerous impulses
6.
acting aggressive or violent
7.
thoughts about suicide or dying
8.
new or worse depression
9.
new or worse anxiety or panic attacks
10.
feeling agitated, restless, angry or irritable
11.
trouble sleeping
12.
an increase in activity or talking more than what is normal for you
13.
other unusual chang

제품 특성 요약

ESCITALOPRAM- ESCITALOPRAM TABLET, FILM COATED
PREFERRED PHARMACEUTICALS, INC.
----------
HIGHLIGHTS OF PRESCRIBING INFORMATION
THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE
ESCITALOPRAM TABLETS SAFELY AND
EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR ESCITALOPRAM
TABLETS.
ESCITALOPRAM TABLETS, FOR ORAL USE
INITIAL U.S. APPROVAL: 2002
WARNING: SUICIDALITY AND ANTIDEPRESSANT DRUGS
_SEE FULL PRESCRIBING INFORMATION FOR COMPLETE BOXED WARNING._
INCREASED RISK OF SUICIDAL THINKING AND BEHAVIOR IN CHILDREN,
ADOLESCENTS AND YOUNG ADULTS TAKING
ANTIDEPRESSANTS FOR MAJOR DEPRESSIVE DISORDER (MDD) AND OTHER
PSYCHIATRIC DISORDERS. ESCITALOPRAM
OXALATE IS NOT APPROVED FOR USE IN PEDIATRIC PATIENTS LESS THAN 12
YEARS OF AGE ( 5.1).
INDICATIONS AND USAGE
Escitalopram oxalate is a selective serotonin reuptake inhibitor
(SSRI) indicated for:
•
•
DOSAGE AND ADMINISTRATION
Indication
Recommended Dose
Recommended: 10 mg once daily
Maximum: 20 mg once daily
MDD in Adults ( 2.1)
Initial: 10 mg once daily
Recommended: 10 mg once daily
Maximum: 20 mg once daily
GAD in Adults ( 2.2)
Initial: 10 mg once daily
Recommended: 10 mg once daily
•
•
•
•
DOSAGE FORMS AND STRENGTHS
•
CONTRAINDICATIONS
•
Acute and Maintenance Treatment of Major Depressive Disorder (MDD) in
adults and adolescents aged 12 to 17
years ( 1.1)
Acute Treatment of Generalized Anxiety Disorder (GAD) in adults ( 1.2)
Escitalopram tablets should generally be administered once daily,
morning or evening with or without food ( 2.1, 2.2).
MDD in Adolescents ( 2.1)
Initial: 10 mg once daily
No additional benefits seen at 20 mg/day dose ( 2.1).
10 mg/day is the recommended dose for most elderly patients and
patients with hepatic impairment ( 2.3).
No dosage adjustment for patients with mild or moderate renal
impairment. Use caution in patients with severe renal
impairment ( 2.3).
Discontinuing escitalopram tablets: A gradual dose reduction is
recommended ( 2.4).
Tablets: 5 mg, 10 mg (scored) and 20 mg (scored) ( 3.1)
Serotonin Syndrome and